G6PD and malaria: Malaria officials directly linked the reduction of vivax presentations to the implementation of G6PD testing (po2), while patients who had not gotten re-infected noticed that after taking complete treatment, they were less likely to get sick again, but they did not link this directly to the availability of testing (pp32).